In vitro and in vivo effects of thiorphan: an inhibitor of enkephalinase a
Chipkin, R.E.; Iorio, L.C.; Barnett, A.; Berger, J.; Billard, W.
Advances in Biochemical Psychopharmacology 33: 235-242
1982
ISSN/ISBN: 0065-2229 PMID: 6751031 Document Number: 185070
Document emailed within 1 workday
Related Documents
Mendelsohn, L.G.; Johnson, B.G.; Scott, W.L.; Frederickson, R.C. 1985: Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo Journal of Pharmacology and Experimental Therapeutics 234(2): 386-390Blum, K.; Wallace, J.E.; DeLallo, L.; Briggs, A.H. 1986: Enkephalinase inhibition by thiorphan and subsequent response of ethanol, normorphine and enkephalins on mouse vas deferens Functional Neurology 1(2): 156-164
Yaksh, T.L.; Sabbe, M.B.; Lucas, D.; Mjanger, E.; Chipkin, R.E. 1991: Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates Journal of Pharmacology and Experimental Therapeutics 256(3): 1033-1041
Baumer, P.; Danquechin Dorval, E.; Bertrand, J.; Vetel, J.M.; Schwartz, J.C.; Lecomte, J.M. 1992: Action of acetorphan, an enkephalinase inhibitor, in acute diarrhea Annales de Gastroenterologie et d'Hepatologie 28(6-7): 279-285
Grubb, M.F.; Diamond, S.; Christ, D.D. 1997: In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(12): 1424-1428
Hara, H.; Tamao, Y.; Kikumoto, R.; Funahara, Y.; Hijikata, A.; Okamoto, S. 1980: Effect of a potent thrombin inhibitor, No. 407, on platelet function in vitro and in vivo Kobe Journal of Medical Sciences 26(1): 47-60
Hussein, E.M.; Dawoud, H.A.; Salem, A.M.; Atwa, M.M. 2009: Antiparasitic activity of cystine protease inhibitor E-64 against Giardia lamblia excystation in vitro and in vivo Journal of the Egyptian Society of Parasitology 39(1): 111-119
Nagase, H.; Enjyoji, K.; Kamikubo, Y.; Kitazato, K.T.; Kitazato, K.; Saito, H.; Kato, H. 1997: Effect of depolymerized holothurian glycosaminoglycan (DHG) on tissue factor pathway inhibitor: in vitro and in vivo studies Thrombosis and Haemostasis 78(2): 864-870
Forough, R.; Koyama, N.; Hasenstab, D.; Lea, H.; Clowes, M.; Nikkari, S.T.; Clowes, A.W. 1996: Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo Circulation Research 79(4): 812-820
Davol, P.A.; Bizuneh, A.; Frackelton, A.R. 1999: Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo Anticancer Research 19(3a): 1705-1713
Wdzieczak-Bakala, J.; Guigon, M.; Lenfant, M.; Frindel, E. 1983: Further purification of a CFU-S inhibitor: in vivo effects after cytosine arabinoside treatment Biomedicine and PharmacoTherapy 37(9-10): 467-471
Kowalski, J.; Belowski, D.; Madej, A.; Herman, Z.S. 1995: Effects of thiorphan, bestatin and captopril on the Lewis lung carcinoma metastases in mice Polish Journal of Pharmacology 47(5): 423-427
Bürki, K.; Stoming, T.A.; Bresnick, E. 1974: Effects of an epoxide hydrase inhibitor on in vivo binding of polycyclic hydrocarbons to DNA and on skin carcinogenesis Journal of the National Cancer Institute 52(3): 785-788
Lishmanov, I.B.; Maslov, L.N.; Uskina, E.V. 2001: Anti-arrhythmia effects of enkephalinase inhibitors Eksperimental'naia i Klinicheskaia Farmakologiia 64(5): 28-30
Fushimi, R.; Matsui, M.; Kunizawa, K.; Hayashi, C.; Miyai, K. 1980: Effects of glycolysis inhibitor on the change of pyruvate concentration in blood in vitro Rinsho Byori. Japanese Journal of Clinical Pathology 28(11): 1149-1152
Bishun, N.P.; Lloyd, N.; Raven, R.W.; Williams, D.C. 1972: The in vitro and in vivo cytogenetic effects of nicotine Acta Biologica Academiae Scientiarum Hungaricae 23(2): 175-180
Tomikawa, S.; Beck, Y.; Watanabe, K.; Kikuchi, K.; Ito, S.; Ando, Y.; Ichikawa, N.; Meigata, K.; Nomura, Y.; Degawa, H.; Nagao, T.; Uchida, H. 1996: Immunosuppressive effects of bactobolamine in vitro and in vivo Transplantation Proceedings 28(2): 1049-1051
Jackman, A.L.; Taylor, G.A.; O'Connor, B.M.; Bishop, J.A.; Moran, R.G.; Calvert, A.H. 1990: Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivo Cancer Research 50(17): 5212-5218
Colman, R.W.; Chang, L.K.; Mukherji, B.; Sloviter, H.A. 1980: Effects of a perfluoro erythrocyte substitute on platelets in vitro and in vivo Journal of Laboratory and Clinical Medicine 95(4): 553-562
Cui, P.-M.; Shu, L.; Liu, F.; Yang, J.-Q.; Song, Y.; Sun, W.-J. 2014: Anti-tumor effects of a novel cyclophosphamide derivate 9b in vivo and in vitro Yao Xue Xue Bao 49(1): 44-49